Literature DB >> 6709116

Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients.

O Giardini, M Taccone-Gallucci, R Lubrano, G Ricciardi-Tenore, D Bandino, I Silvi, U Ruberto, C U Casciani.   

Abstract

Some metabolic alterations of the pentose-phosphate shunt can increase susceptibility to red blood cell (RBC) lipid peroxidation in uraemic patients on maintenance haemodialysis. We investigated this phenomenon in 19 uraemic patients undergoing chronic haemodialysis by determining RBC malonyldialdehyde (MDA), a secondary product of lipid peroxidation and plasma and RBC tocopherols, which are powerful antioxidants. Evidence of RBC membrane lipid peroxidation was demonstrated by an increase of RBC MDA. RBC tocopherols were significantly decreased because of enhanced antioxidant activity. No significant variations of these parameters were found before and after dialysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6709116     DOI: 10.1159/000183160

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  6 in total

1.  Comparative effects of silymarin and vitamin E supplementation on oxidative stress markers, and hemoglobin levels among patients on hemodialysis.

Authors:  Jamshid Roozbeh; Bahram Shahriyari; Masoumeh Akmali; Ghazal Vessal; Maryam Pakfetrat; Ghanbar Ali Raees Jalali; Raha Afshariani; Mahshid Hasheminasab; Nasrollah Ghahramani
Journal:  Ren Fail       Date:  2011       Impact factor: 2.606

2.  Red cell lipid peroxidation and antioxidant system in haemodialysed patients: influence of recombinant human erythropoietin (r-HuEPO) treatment.

Authors:  M Boran; C Küçükaksu; M Balk; S Cetin
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

3.  Effect of recombinant human erythropoietin on synthesis of methylguanidine in uraemic patients on haemodialysis or continuous ambulatory peritoneal dialysis.

Authors:  I Sasagawa; T Nakada; Y Kubota; T Sawamura; H Suzuki; T Hashimoto
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

4.  Creatol (5-hydroxycreatinine), a new toxin candidate in uremic patients.

Authors:  K Nakamura; K Ienaga
Journal:  Experientia       Date:  1990-05-15

5.  The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure.

Authors:  S Túri; I Németh; I Varga; T Bodrogi; B Matkovics
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

6.  Evalution of in vitro effect of flavonoids on human low-density lipoprotein carbamylation.

Authors:  Mohammad Ali Ghaffari; Mehrnoosh Shanaki
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.